Design. Progress. Together.

CureVac Netherlands B.V. is looking for an enthusiastic Scientist Immunology (f/m/d) with experience in immunological research who would like to join a newly established, highly innovative and inspiring Antigen Discovery and Validation Center located in the vibrant and cosmopolitan city of Amsterdam. Our next Scientist Immunology (f/m/d) will be a part of the cross-functional antigen validation team of the Antigen Discovery and Validation Center of CureVac NL.

Scientist Immunology (f/m/d)

Your responsibilities:

Design, planning, and execution of in vitro immunological assays related to the validation of antigens for clinical development of mRNA cancer vaccines
Analysis, recording, and reporting of the data in a comprehensive manner for internal and external discussions
Supervision and management of multiple parallel projects
Close collaboration with the genomic and bioinformatic team in antigen discovery efforts
Collaboration with CROs and academic parties
Collaboration with and (co-)supervision of research associates
Contribution to the further development of the Human Immunology lab both intellectually and technically

Your qualifications:

PhD in Immunology, preferentially with focus on Immuno-Oncology
First postdoctoral experience; candidates with recently obtained PhD will be considered if they have direct experience with relevant immunological assays
MSc in Immunology/Oncology with some years of relevant experience might be considered on an individual basis
Hands on experience with multicolor flow cytometry, primary cell isolation and culturing, ELISA/ELISpot, T cell functional assays
Proactive, structured, and independent way of working
Fluent in spoken and written English

CureVac Netherlands B.V. is part of CureVac AG: a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA) with the main goal to bring multiple best-in-class mRNA drugs to market. As Antigen Discovery and Validation Center, CureVac Netherlands focuses on developing innovative cancer immunotherapies. We will focus on the design and clinical validation of a first off-the-shelf vaccine targeting a number of shared cancer antigens. In parallel, the antigen discovery technology will be improved and expanded with the goal to develop a platform that enables the detection of all possible antigens expressed by cancer cells. Such a platform will form the basis for off-the-shelf and personalized vaccine design for many different cancer types.

We look forward to receiving your application via our CareerPortal.